Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease.

MLA

Soleto, Irene, et al. “Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease.” Biomedicines, vol. 11, no. 10, Oct. 2023, p. 2831. EBSCOhost, https://doi.org/10.3390/biomedicines11102831.

APA

Soleto, I., Ramirez, C., Gómez, C., Baldan-Martin, M., Orejudo, M., Mercado, J., Chaparro, M., & Gisbert, J. P. (2023). Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. Biomedicines, 11(10), 2831. https://doi.org/10.3390/biomedicines11102831

Chicago

Soleto, Irene, Cristina Ramirez, Cristina Gómez, Montse Baldan-Martin, Macarena Orejudo, Jorge Mercado, María Chaparro, and Javier P. Gisbert. 2023. “Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease.” Biomedicines 11 (10): 2831. doi:10.3390/biomedicines11102831.